Healthcare / Drug Manufacturers - GeneralUpdated 2026-05-10 22:07 UTC

TSX/AMGN stock hub

TSX/AMGN has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TSX/AMGNis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

245.1B

Toronto Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TSX/AMGN

In the news

Latest news · TSX/AMGN

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E14.6

P25 11P50 15.6P75 25.4

Trailing P/E22.5

P25 7.4P50 15.6P75 34.3

ROE101.3

P25 -121.5P50 -40.9P75 0.5

ROIC19.1

P25 -72.5P50 -16P75 1.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TSX/AMGN market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

204

Groups with data

Currency

USD

Showing 204 of 204 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	CA
Employees	31,500
Employees Change	3,500%
Employees Change Percent	12.5
Enterprise value	CAD 307.1B
Exchange	Toronto Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Drug Manufacturers - General
Last refreshed	2026-05-10
Market cap	CAD 245.1B
Price	CAD 24.46
Price currency	CAD
Rev Per Employee	1,649,330.45x
Sector	Healthcare
Sic	2836
Symbol	tsx/AMGN
Website	https://www.amgen.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.44%
EV Earnings	28.2x
EV/EBIT	18.47x
EV/EBITDA	13.06x
EV/FCF	25.59x
EV/Sales	6.03x
FCF yield	4.9%
Forward P/E	14.61x
P/B ratio	19.1x
P/E ratio	22.51x
P/S ratio	4.72x
PE Ratio10 Y	25.07x
PE Ratio3 Y	28.82x
PE Ratio5 Y	25.59x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	32.63%
EBITDA Margin	45.45%
FCF margin	23.1%
Gross margin	71.44%
Gross Profit	CAD 37.1B
Gross Profit Growth	12.82%
Gross Profit Growth Q	10.41%
Gross Profit Growth3 Y	10.66%
Gross Profit Growth5 Y	6.92%
Net Income	CAD 10.9B
Net Income Growth	31.47%
Net Income Growth Q	5.15%
Net Income Growth3 Y	-0.5%
Net Income Growth5 Y	1.94%
Pretax Margin	24.41%
Profit Margin	20.96%
Profit Per Employee	CAD 345,642
ROA	8.35
Roa5y	8.22
ROCE	17.98
ROE	101.3
Roe5y	101.8
ROIC	19.05
Roic5y	20.52

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS Growth	31.3
EPS Growth Q	4.38
EPS Growth3 Y	-0.8
EPS Growth5 Y	3.54
FCF Growth	-21.24%
FCF Growth Q	50.71%
FCF Growth3 Y	4.51%
FCF Growth5 Y	-2.65%
OCF Growth	-11.78%
OCF Growth Q	57.37%
OCF Growth10 Y	0.57%
OCF Growth3 Y	7.65%
OCF Growth5 Y	0.55%
Revenue Growth	9.07x
Revenue Growth Q	5.76x
Revenue Growth3 Y	12.43x
Revenue Growth5 Y	8.14x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CAD 0.41
Assets	CAD 129.1B
Cash	CAD 16.8B
Current Assets	CAD 43B
Current Liabilities	CAD 34.1B
Debt	CAD 80B
Debt EBITDA	CAD 3.34
Debt Equity	CAD 6.24
Debt FCF	CAD 6.67
Equity	CAD 12.8B
Interest Coverage	3.92
Liabilities	CAD 116.3B
Long Term Assets	CAD 86.1B
Long Term Liabilities	CAD 82.2B
Net Cash	CAD -63.2B
Net Cash By Market Cap	CAD -25.79
Net Debt EBITDA	CAD 2.68
Net Debt Equity	CAD 4.93
Net Debt FCF	CAD 5.27
Tangible Book Value	CAD -43.1B
Tangible Book Value Per Share	CAD -79.82

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.26
Inventory Turnover	1.65
Net Working Capital	CAD -113.1M
Quick ratio	0.85
Working Capital	CAD 9.1B
Working Capital Turnover	CAD 9.95

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.09%
Dividend Growth	0%
Dividend Growth Years	1%
Dividend per share	CAD 0.72
Dividend Years	2
Dividend Yield	2.94%
Ex Div Date	2026-02-13
Last Dividend	CAD 0.19
Payout Frequency	Quarterly
Payout Ratio	3.58%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
50-day SMA	26.53
All Time High	29.21
All Time High Change	-16.26%
All Time High Date	2026-02-27
All Time Low	23.95
All Time Low Change	2.13%
All Time Low Date	2026-05-05
ATR	0.48
Ch YTD	-1.53
High	24.57
High52	29.21
High52 Date	2026-02-27
High52ch	-16.26%
Low	24.46
Low52	23.95
Low52 Date	2026-05-05
Low52ch	2.13%
Ma50ch	-7.8%
RSI	38.14
RSI Monthly	0
RSI Weekly	0
Sharpe ratio	-0.14x
Sortino ratio	-0.04
Total Return	2.85%
Tr YTD	-0.85
Tr1m	-3.51%
Tr1w	0.2%
Tr3m	-13.83%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CAD 17B
Operating Income Growth	18.32
Operating Income Growth Q	24.43
Operating Income Growth3 Y	8.22
Operating Income Growth5 Y	5.8
Operating margin	32.63

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	538,255,159%
Net Borrowing	21,872,800
Shares Insiders	0.17%
Shares Institutions	82.91%
Shares Qo Q	0.18%
Shares Yo Y	0.09%
Short Ratio	4.77

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CAD 11.3B
Average Volume	9,937.85x
Bv Per Share	23.77
CAPEX	CAD -3B
Ch1m	-3.51
Ch1w	0.2
Ch3m	-14.42
Change	0.04%
Change From Open	-0.45
Close	24.45
Days Gap	0.49
Depreciation Amortization	6,523,562,600
Earnings Date	2026-04-30
EBIT	CAD 17B
EBITDA	CAD 23.6B
EPS	CAD 20.06
F Score	8
FCF	CAD 12B
FCF EV Yield	3.91x
Financing CF	-7,420,391,760
Fiscal Year End	December
Founded	1,980
Goodwill	25,528,291,700
Graham Number	5.59515
Graham Upside	-77.13
Income Tax	CAD 1.8B
Investing CF	-3,087,642,320
Is Primary Listing	0
Last Earnings Date	2026-04-30
Last Report Date	2026-03-31
Lynch Fair Value	CAD 5.43
Lynch Upside	-77.79
Ma20	25.53
Ma20ch	-4.2%
Net CF	4,505,836,080
Next Earnings Date	2026-08-04
Open	24.57
P FCF Ratio	20.42
P OCF Ratio	16.32
Payment Date	2026-03-13
Position In Range	0
Ppne	11,231,682,800
Price Date	2026-05-08
Price EBITDA	CAD 10.38
Relative Volume	0.02x
Revenue	51,953,909,200x
SBC By Revenue	1.3x
Share Based Comp	675,596,240
Tax By Revenue	3.46x
Tax Rate	14.16%
Volume	0
Z Score	1.75

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

TSX/AMGN dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+2.9%

$0.72 annual per share

Payout ratio

+3.6%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

1 consecutive years of growth

Total shareholder yield

+2.8%

Next ex-dividend date: 2026-02-13

Ownership

Who owns TSX/AMGN?

Insider, institutional, and short-interest positioning.

Institutional ownership

+82.9%

Share of float held by funds and institutions

Insider ownership

+0.2%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

TSX/AMGN momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

38.1

Neutral momentum band

Price vs 200-day MA

n/a

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

-0.14

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TSX/AMGN

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tsx/AMGN stock rating?

tsx/AMGN is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tsx/AMGN analysis?

The full report lives at /stocks/tsx/AMGN/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tsx/AMGN?

The latest report frames tsx/AMGN around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tsx/AMGN page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.